A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3R01AI121129-06S1
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites
National Institutes of Health
Grant: 5R01AI177512-03
Development of an Oral Pan-Coronavirus Drug Cocktail
National Institutes of Health
Grant: 5R01HL169427-02
Developing hemophilia A therapeutics by targeting translational and posttranslational regulation of FVIII
NIAID NIH HHS
Grant: R01 AI121129
NIAID NIH HHS
Grant: R01 AI177512
Fields of Study
Keywords
Sustainable Development Goals